{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T17:51:34Z","timestamp":1783792294119,"version":"3.55.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.02069","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T09:40:37Z","timestamp":1597743637000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":87,"title":["Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider"],"prefix":"10.3389","volume":"11","author":[{"given":"Juan","family":"Garcia-Revilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Deierborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Venero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Boza-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease.","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/s2213-2600(20)30222-8","article-title":"Pulmonary fibrosis secondary to COVID-19: a call to arms?","volume":"8","author":"Spagnolo","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/s2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","article-title":"Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis.","volume":"199","author":"Reyfman","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"10696","DOI":"10.1073\/pnas.1104306108","article-title":"Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor.","volume":"108","author":"Peng","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30691-7","article-title":"Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?","volume":"395","author":"Ritchie","year":"2020","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.02.20029975","article-title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome.","author":"Yang","year":"2020","journal-title":"MedRxiv."},{"key":"B10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.","volume":"26","author":"Liao","year":"2020","journal-title":"Nat Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases.","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity."},{"key":"B12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","article-title":"Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease.","volume":"26","author":"Zhou","year":"2020","journal-title":"Nat Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level.","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature."},{"key":"B14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00401-019-02013-z","article-title":"Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer\u2019s disease.","volume":"138","author":"Boza-Serrano","year":"2019","journal-title":"Acta Neuropathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.celrep.2015.02.012","article-title":"Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation.","volume":"10","author":"Burguillos","year":"2015","journal-title":"Cell Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1084\/jem.20141732","article-title":"TREM-2 promotes macrophage survival and lung disease after respiratory viral infection.","volume":"212","author":"Wu","year":"2015","journal-title":"J Exp Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ajpath.2011.09.019","article-title":"TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury.","volume":"180","author":"Yang","year":"2012","journal-title":"Am J Pathol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-020-00240-0","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19040965","article-title":"Oxymatrine inhibits influenza a virus replication and inflammation via TLR4, p38 MAPK and NF-\u03baB Pathways.","volume":"19","author":"Dai","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature12118","article-title":"The TLR4 antagonist Eritoran protects mice from lethal influenza infection.","volume":"497","author":"Shirey","year":"2013","journal-title":"Nature."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98850","article-title":"TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung.","volume":"3","author":"Bhattacharyya","year":"2018","journal-title":"JCI Insight."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/thc-192011","article-title":"Differences of TNF-\u03b1, IL-6 and Gal-3 in lobar pneumonia and bronchial pneumonia caused by mycoplasma pneumoniae.","volume":"20","author":"Tian","year":"2020","journal-title":"Technol Health Care."},{"key":"B23","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2217\/imt-2016-0020","article-title":"Immunotherapeutic implications of IL-6 blockade for cytokine storm.","volume":"8","author":"Tanaka","year":"2016","journal-title":"Immunotherapy."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105982","article-title":"Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies.","volume":"20","author":"Zhao","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"B25","doi-asserted-by":"crossref","first-page":"p. 247","DOI":"10.1007\/978-3-642-03683-5_15","article-title":"SARS coronavirus and lung fibrosis.","author":"Zuo","year":"2010","journal-title":"Molecular Biology of the SARS-Coronavirus."},{"key":"B26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.","volume":"136","author":"Wong","year":"2004","journal-title":"Clin Exp Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/path.2067","article-title":"Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS.","volume":"210","author":"He","year":"2006","journal-title":"J Pathol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-019-0181-7","article-title":"SARS-coronavirus open reading frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes.","volume":"5","author":"Shi","year":"2019","journal-title":"Cell Death Discov."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.ajpath.2017.12.014","article-title":"Galectin-3 enhances avian H5N1 influenza a virus-induced pulmonary inflammation by promoting NLRP3 inflammasome activation.","volume":"188","author":"Chen","year":"2018","journal-title":"Am J Pathol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.4049\/jimmunol.1900212","article-title":"Gasdermin D drives the nonexosomal secretion of galectin-3, an insulin signal antagonist.","volume":"203","author":"Chen","year":"2019","journal-title":"J Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/acr2.11135","article-title":"Continuous intravenous anakinra infusion to calm the cytokine storm in macrophage activation syndrome.","volume":"2","author":"Adam","year":"2020","journal-title":"ACR Open Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality.","volume":"20","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-014-0156-0","article-title":"The role of Galectin-3 in \u03b1-synuclein-induced microglial activation.","volume":"2","author":"Boza-Serrano","year":"2014","journal-title":"Acta Neuropathol Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","article-title":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26.","volume":"9","author":"Vankadari","year":"2020","journal-title":"Emerg Microbes Infect."},{"key":"B35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s13337-020-00571-5","article-title":"Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV).","volume":"31","author":"Kumar","year":"2020","journal-title":"Virusdisease."},{"key":"B36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins.","volume":"3","author":"Li","year":"2016","journal-title":"Annu Rev Virol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41586-020-2332-7","article-title":"Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.","volume":"583","author":"Bojkova","year":"2020","journal-title":"Nature."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20171505","article-title":"Influenza virus N-linked glycosylation and innate immunity.","volume":"39","author":"York","year":"2019","journal-title":"Biosci Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5841","DOI":"10.1128\/jvi.00166-13","article-title":"Binding of transmembrane mucins to galectin-3 limits herpesvirus 1 infection of human corneal keratinocytes.","volume":"87","author":"Woodward","year":"2013","journal-title":"J Virol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00705-009-0351-7","article-title":"Herpes simplex virus type 1 infection increases the carbohydrate binding activity and the secretion of cellular galectin-3.","volume":"154","author":"King","year":"2009","journal-title":"Arch Virol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14817-8","article-title":"Exosomes derived from HIV-1 infected dcs mediate viral trans-infection via fibronectin and galectin-3.","volume":"7","author":"Kulkarni","year":"2017","journal-title":"Sci Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nm.2065","article-title":"Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses.","volume":"16","author":"Pais-Correia","year":"2010","journal-title":"Nat Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2014.12.010","article-title":"Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding.","volume":"65","author":"Nita-Lazar","year":"2015","journal-title":"Mol Immunol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.","volume":"11","author":"Ou","year":"2020","journal-title":"Nat Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/aji.12273","article-title":"Investigation of galectin-3 function in the reproductive tract by identification of binding ligands in human seminal plasma.","volume":"72","author":"Kovak","year":"2014","journal-title":"Am J Reprod Immunol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/307315","article-title":"Angiotensin-converting enzyme 2: the first decade.","volume":"2012","author":"Clarke","year":"2012","journal-title":"Int J Hypertens."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.","volume":"367","author":"Yan","year":"2020","journal-title":"Science."},{"key":"B48","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1128\/aac.03999-14","article-title":"Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2.","volume":"59","author":"Zhao","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00831-20","article-title":"Comparison of Severe acute respiratory syndrome coronavirus 2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts.","volume":"94","author":"Zhai","year":"2020","journal-title":"J Virol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.014873","article-title":"SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics.","volume":"25","author":"Gupta","year":"2020","journal-title":"J Biol Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.","volume":"495","author":"Raj","year":"2013","journal-title":"Nature."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.14.988345","article-title":"SARS-CoV-2 invades host cells via a novel route: CD147-spike protein.","author":"Wang","year":"","journal-title":"BioRxiv."},{"key":"B53","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.2047-2927.2013.00099.x","article-title":"Proteomic identification of galectin-3 binding ligands and characterization of galectin-3 proteolytic cleavage in human prostasomes.","volume":"1","author":"Kovak","year":"2013","journal-title":"Andrology."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070011","article-title":"Galectin-3 induces clustering of CD147 and integrin-\u03b21 transmembrane glycoprotein receptors on the RPE cell surface.","volume":"8","author":"Priglinger","year":"2013","journal-title":"PLoS One."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41423-020-0424-9","article-title":"SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.","volume":"7","author":"Wang","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112147-20200311-00312","article-title":"[Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].","volume":"43","author":"Zhang","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1002\/cbic.201600285","article-title":"Galectin-3-binding glycomimetics that strongly reduce bleomycin-induced lung fibrosis and modulate intracellular glycan recognition.","volume":"17","author":"Delaine","year":"2016","journal-title":"Chembiochem."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01028-2020","article-title":"Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers.","volume":"55","author":"Rello","year":"2020","journal-title":"Eur Respir J."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-317355","article-title":"Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19.","author":"Pagnesi","year":"2020","journal-title":"Heart."},{"key":"B60","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3892\/mmr.2016.6020","article-title":"Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension.","volume":"15","author":"Hao","year":"2017","journal-title":"Mol Med Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"673.e","DOI":"10.1016\/j.jash.2017.07.009","article-title":"Galectin-3 mediates pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension.","volume":"11","author":"Luo","year":"2017","journal-title":"J Am Soc Hypertens."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1164\/rccm.201711-2308LE","article-title":"Galectin-3 promotes vascular remodeling and contributes to pulmonary hypertension.","volume":"197","author":"Barman","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"L784","DOI":"10.1152\/ajplung.00186.2018","article-title":"Galectin-3 is expressed in vascular smooth muscle cells and promotes pulmonary hypertension through changes in proliferation, apoptosis, and fibrosis.","volume":"316","author":"Barman","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s10096-013-1919-4","article-title":"Circulating galectin-3 in infections and non-infectious inflammatory diseases.","volume":"32","author":"Ten Oever","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1164\/rccm.201509-1753OC","article-title":"Galectin-3 is associated with restrictive lung disease and interstitial lung abnormalities.","volume":"194","author":"Ho","year":"2016","journal-title":"Am J Respir Crit Care Med."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20180308","article-title":"Therapeutic effects of simvastatin on Galectin-3 and oxidative stress parameters in endotoxemic lung tissue.","volume":"38","author":"Yorulmaz","year":"2018","journal-title":"Biosci Rep."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/biom10030389","article-title":"Galectin-3 as a next-generation biomarker for detecting early stage of various diseases.","volume":"10","author":"Hara","year":"2020","journal-title":"Biomolecules."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.4049\/jimmunol.168.4.1813","article-title":"Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia.","volume":"168","author":"Sato","year":"2002","journal-title":"J Immunol."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17292-4","article-title":"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.","volume":"11","author":"De Biasi","year":"2020","journal-title":"Nat Commun."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02069\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T09:40:41Z","timestamp":1597743641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02069\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":69,"alternative-id":["10.3389\/fimmu.2020.02069"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.02069","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,18]]},"article-number":"2069"}}